Microbiology and Immunology

You are here

Home > Publications > Publications

Publications

Found 71 results
Author Title Type [ Year(Desc)]
Filters: Author is Ma, Xiaojing  [Clear All Filters]
2015
Kim H, Zhao Q, Zheng H, Li X, Zhang T, Ma X.  2015.  A novel crosstalk between TLR4- and NOD2-mediated signaling in the regulation of intestinal inflammation.. Sci Rep. 5:12018.
2016
Yan W, Ding A, Kim H-J, Zheng H, Wei F, Ma X.  2016.  Progranulin Controls Sepsis via C/EBPα-Regulated Il10 Transcription and Ubiquitin Ligase/Proteasome-Mediated Protein Degradation.. J Immunol. 197(8):3393-3405.
2017
Liao L, Song M, Li X, Tang L, Zhang T, Zhang L, Pan Y, Chouchane L, Ma X.  2017.  E3 Ubiquitin Ligase UBR5 Drives the Growth and Metastasis of Triple-Negative Breast Cancer.. Cancer Res. 77(8):2090-2101.
Zhang L, Adileh M, Martin MLaura, Klingler S, White J, Ma X, Howe LR, Brown AMC, Kolesnick R.  2017.  Establishing estrogen-responsive mouse mammary organoids from single Lgr5 cells.. Cell Signal. 29:41-51.
Murray HW, Luster AD, Zheng H, Ma X.  2017.  Gamma Interferon-Regulated Chemokines in Leishmania donovani Infection in the Liver.. Infect Immun. 85(1)
Zhao Q, Du Q, Wei F, Xie J, Ma X.  2017.  An Infectious Disease-Associated Il12b Polymorphism Regulates IL-12/23 p40 Transcription Involving Poly(ADP-Ribose) Polymerase 1.. J Immunol. 198(7):2935-2942.
Ban Y, Mai J, Li X, Mitchell-Flack M, Zhang T, Zhang L, Chouchane L, Ferrari M, Shen H, Ma X.  2017.  Targeting Autocrine CCL5-CCR5 Axis Reprograms Immunosuppressive Myeloid Cells and Reinvigorates Antitumor Immunity.. Cancer Res. 77(11):2857-2868.
2018
Zhang W, Kim H, Lv J, Zhao N, Ma X.  2018.  Golgi Phosphoprotein 2 Is a Novel Regulator of IL-12 Production and Macrophage Polarization.. J Immunol. 200(4):1480-1488.
Schlitzer A, Zhang W, Song M, Ma X.  2018.  Recent advances in understanding dendritic cell development, classification, and phenotype.. F1000Res. 7
Ma X.  2018.  Sensing danger through a "finger".. J Exp Med. 215(12):2969-2971.
Rafiq S, Yeku OO, Jackson HJ, Purdon TJ, van Leeuwen DG, Drakes DJ, Song M, Miele MM, Li Z, Wang P et al..  2018.  Targeted delivery of a PD-1-blocking scFv by CAR-T cells enhances anti-tumor efficacy in vivo.. Nat Biotechnol. 36(9):847-856.
2019
Ban Y, Dong W, Zhang L, Zhou T, Altiti AS, Ali K, Mootoo DR, Blaho VA, Hla T, Ren Y et al..  2019.  Abrogation of Endogenous Glycolipid Antigen Presentation on Myelin-Laden Macrophages by D-Sphingosine Ameliorates the Pathogenesis of Experimental Autoimmune Encephalomyelitis.. Front Immunol. 10:404.
Hu W, Zi Z, Jin Y, Li G, Shao K, Cai Q, Ma X, Wei F.  2019.  CRISPR/Cas9-mediated PD-1 disruption enhances human mesothelin-targeted CAR T cell effector functions.. Cancer Immunol Immunother. 68(3):365-377.
Wang C, Li Y, Chu C-M, Zhang X-M, Ma J, Huang H, Wang Y-N, Hong T-Y, Zhang J, Pan X-W et al..  2019.  Gankyrin is a novel biomarker for disease progression and prognosis of patients with renal cell carcinoma.. EBioMedicine. 39:255-264.
Shan J, Chouchane A, Mokrab Y, Saad M, Boujassoum S, Sayaman RW, Ziv E, Bouaouina N, Remadi Y, Gabbouj S et al..  2019.  Genetic Variation in CCL5 Signaling Genes and Triple Negative Breast Cancer: Susceptibility and Prognosis Implications.. Front Oncol. 9:1328.
Wei F, Jiang Z, Sun H, Pu J, Sun Y, Wang M, Tong Q, Bi Y, Ma X, Gao GFu et al..  2019.  Induction of PGRN by influenza virus inhibits the antiviral immune responses through downregulation of type I interferons signaling.. PLoS Pathog. 15(10):e1008062.
Voshtani R, Song M, Wang H, Li X, Zhang W, Tavallaie MS, Yan W, Sun J, Wei F, Ma X.  2019.  Progranulin promotes melanoma progression by inhibiting natural killer cell recruitment to the tumor microenvironment.. Cancer Lett. 465:24-35.
2020
Wang H, Wang C, Peng G, Yu D, Cui X-G, Sun Y-H, Ma X.  2020.  Capping Protein Regulator and Myosin 1 Linker 3 Is Required for Tumor Metastasis.. Mol Cancer Res. 18(2):240-252.
Moallemian R, Rehman AUr, Zhao N, Wang H, Chen H, Lin G, Ma X, Yu J.  2020.  Immunoproteasome inhibitor DPLG3 attenuates experimental colitis by restraining NF-κB activation.. Biochem Pharmacol. 177:113964.
Ma X.  2020.  The omentum, a niche for premetastatic ovarian cancer.. J Exp Med. 217(4)
Song M, Wang C, Wang H, Zhang T, Li J, Benezra R, Chouchane L, Sun Y-H, Cui X-G, Ma X.  2020.  Targeting ubiquitin protein ligase E3 component N-recognin 5 in cancer cells induces a CD8+ T cell mediated immune response.. Oncoimmunology. 9(1):1746148.